We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Biogen

News List

Biogen’s Imraldi, an adalimumab biosimilar candidate referencing Humira, granted positive opinion by cphi-online
June 27, 2017
If approved, Imraldi will be the third anti-TNF biosimilar in Biogen’s portfolio in Europe.
Biogen Acquires Remedy Pharmaceuticals’ Cirara for Large Hemispheric Stroke americanpharmaceuticalreview
May 16, 2017
Biogen announced it has completed an asset purchase of Remedy Pharmaceuticals’ Phase 3 candidate, Cirara (intravenous glyburide).
US patent office upholds Biogen's patent for Tecfidera firstwordpharma
March 22, 2017
The US Patent and Trademarks Office's Patent Trial and Appeal Board on Tuesday upheld the validity of a patent protecting Biogen's multiple sclerosis treatment Tecfidera (dimethyl fumarate)‎ following a challenge by hedge fund manager Kyle Bass.
Biogen Appoints RED SVP contractpharma
March 20, 2017
Ghosh will lead discovery and development efforts from idea through proof of concept
Biogen reaches $1.25-billion settlement, licensing agreement with Forward Pharma in MS drug patent d firstwordpharma
January 18, 2017
Biogen announced Tuesday that it has agreed to enter a $1.25-billion settlement and licensing agreement with Forward Pharma under which it will obtain an irrevocable license to all of the latter's intellectual property.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page